Edition:
United Kingdom

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

73.40USD
25 Sep 2018
Change (% chg)

$1.65 (+2.30%)
Prev Close
$71.75
Open
$71.70
Day's High
$74.10
Day's Low
$70.80
Volume
251,156
Avg. Vol
221,545
52-wk High
$85.05
52-wk Low
$23.25

Chart for

About

REGENXBIO Inc. is a clinical-stage biotechnology company. The Company's gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. The Company develops products candidates... (more)

Overall

Beta: --
Market Cap(Mil.): $1,039.60
Shares Outstanding(Mil.): 30.89
Dividend: --
Yield (%): --

Financials

  RGNX.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -2.72 -- --
ROI: -36.22 1.79 14.61
ROE: -36.40 3.28 16.33

BRIEF-Regenxbio Receives $100 Mln Accelerated License Payment

* REGENXBIO RECEIVES $100 MILLION ACCELERATED LICENSE PAYMENT DUE TO ACQUISITION OF AVEXIS BY NOVARTIS

11 Jun 2018

BRIEF-Regenxbio Reports Q1 Earnings Per Share $3.04

* REGENXBIO REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS

08 May 2018

Earnings vs. Estimates